Last $1.03 USD
Change Today 0.00 / 0.00%
Volume 1.1M
AMRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

amarin corp plc -adr (AMRN) Snapshot

Open
$1.04
Previous Close
$1.03
Day High
$1.05
Day Low
$1.03
52 Week High
09/10/14 - $2.09
52 Week Low
11/11/14 - $0.78
Market Cap
179.4M
Average Volume 10 Days
852.7K
EPS TTM
$-1.03
Shares Outstanding
174.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMARIN CORP PLC -ADR (AMRN)

amarin corp plc -adr (AMRN) Related Businessweek News

No Related Businessweek News Found

amarin corp plc -adr (AMRN) Details

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

185 Employees
Last Reported Date: 02/27/14
Founded in 1989

amarin corp plc -adr (AMRN) Top Compensated Officers

Chief Executive Officer, President, Assistant...
Total Annual Compensation: $395.2K
Senior Vice President and President of Resear...
Total Annual Compensation: $384.3K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $358.0K
Compensation as of Fiscal Year 2013.

amarin corp plc -adr (AMRN) Key Developments

Amarin Corporation plc Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 11:00 AM

Amarin Corporation plc Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 11:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: John F. Thero, Chief Executive Officer, President, Assistant Secretary and Director.

Amarin Corporation plc(NasdaqGM:AMRN) dropped from NASDAQ Biotechnology Index

Amarin Corporation plc will be removed from the NASDAQ Biotechnology Index.

Amarin Corporation plc Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 03:20 PM

Amarin Corporation plc Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 03:20 PM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: John F. Thero, Chief Executive Officer, President, Assistant Secretary and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $1.03 USD 0.00

AMRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $70.55 USD -0.81
BioMarin Pharmaceutical Inc $99.58 USD +0.07
Enzymotec Ltd $7.05 USD +0.03
Jazz Pharmaceuticals PLC $174.53 USD -2.25
Regeneron Pharmaceuticals Inc $415.74 USD -8.03
View Industry Companies
 

Industry Analysis

AMRN

Industry Average

Valuation AMRN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit www.amarincorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.